Clinical and Experimental Allergy Journal - BSACI

Clinical and Experimental Allergy Journal

Clinical & Experimental Allergy was launched in 1971 and has been the official journal of the British Society for Allergy & Clinical Immunology ever since. Published for the BSACI by Wiley-Blackwell, all the journal’s content, including free virtual issues, accepted articles published online in advance of issues, and the archive of content reaching as far back as the first article by Jack Pepys on clinical immunology and the ‘practise of allergy’ can be found on the journal’s website.

For information on how to become a BSACI member which includes being able to access the journal online, click here.

Members can access the journal through the Member’s area which can be accessed here.

 

Aims and Scope

Clinical & Experimental Allergy caters to clinicians and scientists working in all fields in which allergic sensitivity plays a part. As well as original articles, the journal carries regular reviews and editorials written by leading authorities in their field. Emphasis is placed on work which enables clinicians to apply immunological methods and procedures to investigation and treatment.

The journal’s readership consists of practising clinicians (including pulmonary specialists, paediatricians, dermatologists and gastro-enterologists), as well as researchers in hospitals and commercial laboratories and in the pharmaceutical industry. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms.

In determining content, the primary considerations are excellence, relevance and novelty. While Clinical & Experimental Allergy reflects the broad scientific and clinical interests of the BSACI membership, the editorial team, led by Professor Graham Roberts, ensures that the journal’s ethos, authorship, content and purpose are those expected of a leading international publication.

  • Experimental Allergy reflects the broad scientific and clinical interests of the BSACI membership
  • The journal’s readership consists of practising clinicians
  • Emphasis is placed on work which enables clinicians to apply immunological methods
  • Researchers in hospitals and commercial laboratories and in the pharmaceutical industry

Submission of papers

Papers should be submitted online via ScholarOne Manuscripts (formerly known as Manuscript Central). Please ensure you have read the Author Guidelines prior to submission. To find out more information please click here